China’s PIONEER pilot, implemented in September, supports new approaches to drug testing, including human tissue models and computer simulations. The programme plans to publish lists of validated methods, case studies and key technical points.
The article argues that PIONEER should also make the evidence behind regulatory decisions available for public scrutiny.
Sources: Nature.